Ningzhen Fu

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Prognostic Factors

Coronavirus Disease

Patient Reported Outcomes

Chemotherapy Induced

Top Venues

Aging and cancer

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ningzhen Fu, Kai Qin, Jingfeng Li, Jiabin Jin, Yu Jiang, Xiaxing Deng, Baiyong Shen
Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate-adjusted analysis at the pre-adjuvant chemotherapy timing. Cancer medicine 11 (18) (2022)
Ningzhen Fu, Yu Jiang, Zhiwei Xu, Meng Yang, Chenghong Peng, Xiaxing Deng, Shulin Zhao, Baiyong Shen
The impact of Omicron pandemic and COVID-19 vaccination on the pancreatic adenocarcinoma patients. Aging and cancer 3 (3-4) (2022)
Ningzhen Fu, Yu Jiang, Zhiwei Xu, Meng Yang, Chenghong Peng, Xiaxing Deng, Shulin Zhao, Baiyong Shen
The impact of Omicron pandemic and COVID-19 vaccination on the pancreatic adenocarcinoma patients. Aging and cancer 3 (3-4) (2022)
Ningzhen Fu, Yu Jiang, Yuanchi Weng, Hao Chen, Xiaxing Deng, Baiyong Shen
Worth it or not? Primary tumor resection for stage IV pancreatic cancer patients: A SEER-based analysis of 15,836 cases. Cancer medicine 10 (17) (2021)